Check-Cap Ltd. (CHEK)

NASDAQ: CHEK · IEX Real-Time Price · USD
0.331
-0.027 (-7.54%)
At close: May 20, 2022 3:59 PM
0.335
0.004 (1.208%)
After-hours:May 20, 2022 6:42 PM EDT
Market Cap38.53M
Revenue (ttm)n/a
Net Income (ttm)-13.85M
Shares Out116.41M
EPS (ttm)-0.21
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume529,607
Open0.360
Previous Close0.358
Day's Range0.331 - 0.362
52-Week Range0.302 - 1.909
Beta0.36
AnalystsBuy
Price Target2.04 (+516.3%)
Earnings DateMay 25, 2022

About CHEK

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application tha...

IndustryHealth Care Equipment & Supplies
IPO DateFeb 19, 2015
CEOAlex Ovadia
Employees81
Stock ExchangeNASDAQ
Ticker SymbolCHEK
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for CHEK stock is "Buy." The 12-month stock price forecast is 2.04, which is an increase of 516.31% from the latest price.

Price Target
$2.04
(516.31% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Check-Cap Announces Initiation of the U.S. Pivotal Trial

ISFIYA, Israel , May 11, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Sc...

1 week ago - PRNewsWire

Check-Cap Reports Fourth Quarter and Full Year 2021 Financial Results

Company anticipates initiation of the first part of its U.S. pivotal study in April 2022 ISFIYA, Israel , April 7, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NAS...

1 month ago - PRNewsWire

Check-Cap Ltd. Announces $10 Million Registered Direct Offering

ISFIYA, Israel, March 1, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-S...

2 months ago - PRNewsWire

FDA Gives Green To Check-Cap's Pivotal Study For Capsule-Based Colorectal Cancer Screening Test

The FDA has approved Check-Cap Ltd's (NASDAQ: CHEK) amended Investigational Device Exemption (IDE) application to initiate the U.S. pivotal study of C-Scan. The U.S. pivotal study consists of two parts.

3 months ago - Benzinga

Check-Cap Announces FDA Approval of Amended IDE Application for Pivotal Study of C-Scan

ISFIYA, Israel, Feb. 7, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Sc...

3 months ago - PRNewsWire

Check-Cap Issues Letter to Shareholders

ISFIYA, Israel, Jan. 5, 2022 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Sc...

4 months ago - PRNewsWire

Check-Cap Announces Receipt of Nasdaq Minimum Bid Price Notification

ISFIYA, Israel, Dec. 23, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-S...

4 months ago - PRNewsWire

Check-Cap Announces Publication of Peer-Reviewed Article Highlighting Safety and Patient Satisfaction Data for its Co...

ISFIYA, Israel, Nov. 22, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-S...

5 months ago - PRNewsWire

Check-Cap Reports Third Quarter 2021 Financial Results and Corporate Update

ISFIYA, Israel, Nov. 3, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Sc...

6 months ago - PRNewsWire

5 Penny Stocks To Buy According To Analysts & Price Targets Up To 175%

Some of the best penny stocks 2021 has offered were some of… The post 5 Penny Stocks To Buy According To Analysts & Price Targets Up To 175% appeared first on Penny Stocks to Buy, Picks, News and Inform...

Other symbols:CCOCLXTGERNKULR
6 months ago - PennyStocks

Check-Cap Announces Grant of Patent Covering C-Scan's Proprietary Tracking Technology in the U.S. and Additional Majo...

ISFIYA, Israel, Nov. 2, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Sca...

6 months ago - PRNewsWire

Top Penny Stocks To Buy For Under $5 On WeBull

A penny stocks list for the end of October The post Top Penny Stocks To Buy For Under $5 On WeBull appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:CEIKULR
7 months ago - PennyStocks

Check-Cap Announces Expansion of Manufacturing Capacity and Production Line to Support U.S. Pivotal Study Initiation

ISFIYA, Israel, Oct. 18, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-S...

7 months ago - PRNewsWire

Check-Cap Appoints Dr. Hanit Brenner-Lavie as Vice President of Clinical Affairs

ISFIYA, Israel, Sept. 1, 2021 /PRNewswire/ -- Check-Cap Ltd.

8 months ago - PRNewsWire

Check-Cap Reports Second Quarter 2021 Financial Results and Corporate Update

ISFIYA, Israel, Aug. 5, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Sc...

9 months ago - PRNewsWire

Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist

Biotech penny stocks are in focus; here's 4 to watch right now The post Best Biotech Penny Stocks to Buy in July 2021? 6 For Your Watchlist appeared first on Penny Stocks to Buy, Picks, News and Informa...

Other symbols:ACSTSEELWORX
10 months ago - PennyStocks

Check-Cap Ltd. Announces $35 Million Registered Direct Offering

ISFIYA, Israel, June 30, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-S...

10 months ago - PRNewsWire

Check-Cap Reports First Quarter 2021 Financial Results and Corporate Update

ISFIYA, Israel, May 12, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Sc...

1 year ago - PRNewsWire

Mark a Major Medical Milestone with Check-Cap

Why should you check out CHEK stock? An FDA approval, along with an impressive year-end capital position, provide a solid case for Check-Cap.

1 year ago - InvestorPlace

Check-Cap Reports Fourth Quarter and Full Year 2020 Financial Results

ISFIYA, Israel, March 19, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-...

1 year ago - PRNewsWire

CHEK Stock: The Big FDA News That Has Check-Cap Shares Skyrocketing Today

Check-Cap (CHEK) stock is heading higher on Monday after the company announced approval from the FDA for one of its devices. The post CHEK Stock: The Big FDA News That Has Check-Cap Shares Skyrocketing ...

1 year ago - InvestorPlace

FDA Signs Off Check-Cap's Pivotal Study For Capsule-Based Colorectal Cancer Screening Technology

Check-Cap Ltd (NASDAQ: CHEK) stock is moving higher on heavy volume in the premarket session after the FDA approved its Investigational Device Exemption (IDE) application, permitting Check-Cap to begin ...

1 year ago - Benzinga

Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan®

ISFIYA, Israel, March 15, 2021 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-...

1 year ago - PRNewsWire

Check-Cap Ltd.: 6 Things for Potential CHEK Stock Investors to Know About the Biotech Company

Check-Cap Ltd. (CHEK) stock is on the rise Monday despite a lack of news from the maker of the C-Scan colorectal cancer screening device.

1 year ago - InvestorPlace

CheckCap Ltd. (CHEK) Upgraded to Buy: Here's What You Should Know

CheckCap Ltd. (CHEK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

1 year ago - Zacks Investment Research